IA
NVO

Insight Advisors’s Novo Nordisk NVO Stock Holding History

Insight Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Sell
5,631
-963
-15% -$41.4K 0.05% 202
2026
Q1 		$242K Buy
6,594
+421
+7% +$19.9K 0.05% 214
2025
Q4 		$314K Sell
6,173
-279
-4% -$14.3K 0.05% 209
2025
Q3 		$358K Buy
6,452
+1,873
+41% +$110K 0.05% 189
2025
Q2 		$316K Sell
4,579
-247
-5% -$16.8K 0.05% 207
2025
Q1 		$335K Sell
4,826
-1,999
-29% -$165K 0.06% 197
2024
Q4 		$585K Buy
6,825
+1,747
+34% +$189K 0.1% 138
2024
Q3 		$605K Sell
5,078
-31
-0.6% -$4.13K 0.1% 137
2024
Q2 		$729K Buy
5,109
+888
+21% +$118K 0.13% 114
2024
Q1 		$542K Buy
4,221
+1,050
+33% +$125K 0.1% 147
2023
Q4 		$328K Buy
+3,171
New +$314K 0.07% 200

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Insight Advisors's NVO Position: Q2 2026 in Review

Insight Advisors reduced its Novo Nordisk (NVO) stake by 15% in Q2 2026, selling an estimated $41.4K and leaving 5,631 shares worth $270K. The position accounts for 0.05% of the portfolio, ranked #202.

Insight Advisors first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $729K in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Insight Advisors held 5,631 shares of Novo Nordisk worth $270K as of Q2 2026.
  • Insight Advisors sold 963 Novo Nordisk shares in Q2 2026, an estimated $41.4K.
  • Novo Nordisk made up 0.05% of Insight Advisors's portfolio in Q2 2026, its #202 holding.
  • Insight Advisors first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
  • Insight Advisors's Novo Nordisk position peaked at $729K in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Insight Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.